Latest News
12/04/2009
“DEGARELIX (FIRMAGON®) VS LEUPROLIDE (LUPRON DEPOT®) IN PATIENTS WITH ADVANCED PROSTATE CANCER: FURTHER ANALYSIS FROM A PHASE III PIVOTAL TRIAL”
Investigators Presented Results at the Society of Urologic Oncology Annual Meeting BETHESDA, MD &nd...
10/20/2009
“RESEARCH COMPARES MENOPUR® WITH rFSH IN GNRH ANTAGONIST IVF CYCLES”
Ferring Pharmaceuticals Presents Study Results at American Society for Reproductive Medicine Annual ...
08/31/2009
“RECENTLY PUBLISHED STUDY DEMONSTRATES PHARMACOKINETIC ADVANTAGES OF ENDOMETRIN® OVER CRINONE® FOR PROGESTERONE SUPPLEMENTATION”
Study Published Online in Fertility & Sterility PARSIPPANY, NJ – August 31, 2009 – ...
08/04/2009
“FERRING PHARMACEUTICALS ANNOUNCES TRADE NAME FIRMAGON® (degarelix for injection) FOR ADVANCED PROSTATE CANCER TREATMENT”
PARSIPPANY, NJ – August 4, 2009 – Ferring Pharmaceuticals announced today that the U.S. ...
05/13/2009
“FERRING PHARMACEUTICALS UNVEILS SIX-MONTH EFFICACY DATA FOR EUFLEXXA® FOR THE TREATMENT OF OSTEOARTHRITIS KNEE PAIN”
Results Show Superior Decrease in Pain Scores Compared to Saline PARSIPPANY, NJ – May 13, 200...
The Ferring USA Product Line
 |
 |
 |
  |
||